Propanc Biopharma (PPCB) Preferred Dividend Payments (2021 - 2025)
Propanc Biopharma (PPCB) posted quarterly Preferred Dividend Payments of $932246.0 for Q4 2025, up 5800.29% quarter-over-quarter from $15800.0 in Q1 2024.
Propanc Biopharma (PPCB) Preferred Dividend Payments (2021 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Preferred Dividend Payments for 5 consecutive years, with $932246.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Preferred Dividend Payments changed N/A year-over-year to $932246.0; the TTM figure through Dec 2025 stood at $982631.0 (changed N/A YoY), while the FY2024 annual figure was $192960.0, down 58.62% from the prior year.
- Preferred Dividend Payments improved to $932246.0 in Q4 2025 per PPCB's latest filing, from $15800.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $932246.0 in Q4 2025 and bottomed at $15800.0 in Q1 2024.
- Historically, Preferred Dividend Payments has averaged $208347.2 across 5 years, with a median of $114844.0 in 2021.
- On a YoY basis, Preferred Dividend Payments climbed as much as 238.92% in 2022 and fell as far as 79.31% in 2022.
- Propanc Biopharma's Preferred Dividend Payments stood at $93398.0 in 2021, then plunged by 79.31% to $19322.0 in 2022, then surged by 78.99% to $34585.0 in 2023, then slumped by 54.32% to $15800.0 in 2024, then jumped by 5800.29% to $932246.0 in 2025.
- Business Quant data shows PPCB's Preferred Dividend Payments at $932246.0 in Q4 2025, $15800.0 in Q1 2024, and $34585.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - | 932,246.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 932,246.00 |
| Mar 31, 2024 | 15,800.00 |
| Dec 31, 2023 | 34,585.00 |
| Sep 30, 2023 | 142,575.00 |
| Jun 30, 2023 | 57,716.00 |
| Dec 31, 2022 | 19,322.00 |
| Sep 30, 2022 | 389,235.00 |
| Jun 30, 2022 | 254,709.00 |
| Mar 31, 2022 | 237,389.00 |
| Dec 31, 2021 | 93,398.00 |
| Sep 30, 2021 | 114,844.00 |